Partnership Forum: Participants discussed how digital therapeutics with web and designed based applications are emerging as a means to treat conditions by engaging people to improve health and wellness.
A retrospective claims data analysis published in JMCP found that patients with metastatic melanoma treated with PD-1 had substantially lower costs than patients treated with other first line agents.
A retrospective claims data analysis published in JMCP found that patients with metastatic melanoma treated with PD-1 had substantially lower costs than patients treated with other first line agents.
Press Release: AMCP Foundation's 8th Annual Research Symposium Discusses Health Care Trends, Disruptors and Opportunities
Press Release: Academy of Managed Care Pharmacy Kicks Off AMCP Nexus 2018: Preparing for the Next Generation of Care
